Navigation Links
National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
Date:9/4/2007

RESTON, Va., Sept. 4 /PRNewswire-USNewswire/ -- The National Pharmaceutical Council (NPC) announced today a new strategic focus on evidence-based medicine (EBM) for health care decision making.

While NPC's overarching mission remains to sponsor and conduct scientific analyses of the appropriate use of pharmaceuticals and the clinical and economic value of pharmaceutical innovation, the focus on EBM represents a new priority for NPC. NPC will be reorganizing and hiring additional staff with the clinical, scientific, and methodological expertise necessary to the focus on EBM.

"NPC has always worked on behalf of the research-based pharmaceutical industry to anticipate pivotal issues, engage with stakeholders to shape workable solutions, and sponsor research to inform choices facing health care decision makers," said Joseph M. Mahady, President of Global Business for Wyeth Pharmaceuticals and NPC Board Chairman. "In prioritizing NPC's activities, the Board unanimously agreed that NPC should focus on evidenced-based coverage and access as the highest priority moving forward."

The new focus on EBM will build on NPC's history of working with researchers, patients, medical professionals, and payers, including employers and government officials. Recent NPC work on EBM has included engagement with the Institute of Medicine Roundtable on Evidence-Based Medicine, the Agency for Healthcare Research and Quality (AHRQ), and the Health Industry Forum. In pursuing its new focus on EBM, NPC will:

-- Facilitate dialogue between the pharmaceutical industry and other

stakeholders;

-- Create awareness and understanding of industry expertise and

perspectives on EBM; and

-- Participate with major stakeholders in the EBM policy debate and

the pursuit of solutions.

Coinciding with the announcement of the new strategic focus, NPC President Karen Williams has announced she will be leaving her current position. According to Mahady, Williams encouraged and guided the Board's adoption of EBM as the focus for NPC and advocated for the reorganization and a search for new leadership. "It's been a privilege to work with the Board and staff, and I'm proud of what we have accomplished," said Ms. Williams.

"Karen has been a terrific resource and leader to the pharmaceutical industry for much of her professional career, especially in her role as NPC's President for the last 11 years," Mahady said. "We will certainly miss her tremendous health policy experience and wisdom, her enthusiasm, drive, and leadership on behalf of NPC and its member companies." Williams has agreed to remain at the helm of NPC during the search for her successor in order to help assure a successful transition.

Mahady said NPC is working with the Washington, DC office of the executive search firm of Korn/Ferry International to direct the search for the next President of the organization. NPC is working with Boyden Executive Search Firm in Atlanta for other senior staff positions, including a Vice President of Clinical and Scientific Affairs and a Research Director.

NPC was established in 1953 and is supported by approximately 20 of the nation's major research-based pharmaceutical companies.

NPC Contact: Pat Adams 703-606-2365; padams@npcnow.com

Korn/Ferry Contact: Lorraine Lavet (202) 955-0943; lorraine.lavet@kornferry.com

Boyden Contact: Deborah Coogan Seltzer 770/618-7655; dseltzer@boyden.com


'/>"/>
SOURCE National Pharmaceutical Council
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. International community warns India on HIV situation
2. National Lung Study in the process
3. Indian Nationals with Foreign Medical Degrees can now practice in India
4. Key step forward on International Health Rules
5. ICMR along with other International Research organisation with drug development for Neglected Diseases
6. International Osteoporosis Research Centre To Be Started In India.
7. Hepatitis B Vaccine To Be Included In National Immunization Programme
8. Indian hospitals require International Accreditation
9. International Conference On Malaria - Laveran To Genomics
10. UK Govt Says On Course For National Chlamydia Screening
11. Delhi To Host International Women’s Congress From Nov 2
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... A recent report from the ... teacher preparation programs. The NCTQ report suggests, based on a review of GPA and ... improve teacher quality in the U.S. It argues that this higher bar should be ...
(Date:3/23/2017)... ... , ... The IoT (Internet of Things) is revolutionizing the way the world ... businesses and individual consumers alike. Laboratories can maximize their profit margin by increasing ... $4 trillion to $11 trillion dollars by the year 2025. McKinsey expects the IoT ...
(Date:3/23/2017)... ... March 23, 2017 , ... Benefits ... an innovative mobile app and centralized benefits dashboard solving one of the top ... from multiple locations. For the first time, employees can access up-to-date information and ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... businesses of the greater Fort Collins area, has unveiled a collaboration with nonprofit ... involvement program. Donations to this worthy cause may now be made at ...
(Date:3/23/2017)... ... March 23, 2017 , ... ChenMed, a privately owned ... of the strategic executive team expansion needed to further optimize growth and performance. ... team,” says Christopher Chen, MD, ChenMed Chief Executive Officer. “George Wheeler and ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... FRANCISCO , March 23, 2017  The ... interoperable system to identify and track prescription drugs as ... , in response to requirements from US FDA ... removal of potentially dangerous medicines. Blockchain ... with cryptographic identity chips and blockchain technology and recently ...
(Date:3/23/2017)... York , March 23, 2017 ... a consolidated vendor landscape with the top five ... market in 2015. These companies are Stryker Sustainability ... Hygia Health Services, Inc., and VANGUARD AG. Despite ... medical devices market is witnessing the prevalence of ...
(Date:3/23/2017)... CAMBRIDGE, Mass. , March 23, 2017 ... the enrollment of its first patient in a Phase ... an antibody-directed nanotherapeutic (ADN) that encapsulates a novel taxane ... suggest is overexpressed in 50-100% of many major tumor ... cancers. "The initiation of this study is ...
Breaking Medicine Technology: